Skip to content
Kalpvruksh Markets
Offline Log in

NATCOPHARMNSEOffline

NATCO PHARMA · INE987B01026 · Small Cap · #389
796.60+7.85 (+1.00%)last close · 05 Nov 2026
Prev close
788.75
Open
—
High
—
Low
—
Volume
—
Mkt cap (6-mo avg)
₹17,418 cr
52-week range · to 05 Nov 2026781.61,206

Loading minute bars…

NSE 1-minute bars from our CandleApi gateway (history from 21 Jul 2026); longer timeframes are built from them. Prices not adjusted for corporate actions.

NATCOPHARM is 34% below its 52-week high, below its 200-day average, behind Healthcare by 14.0 pts over 3 months — a Small Cap company, #389 by market cap.NSE prices to 05 Nov 2026 · a description of the data, not advice

Overview

What the data says, line by line

A description, never a buy or sell word · tap a line for its detail

  • above its 20-day average · below its 50 / 200-day averages · 34% below its 52-week high
  • behind its industry by 14.0 pts over 3 months · rank 40 of 44 in Healthcare · −11.3% vs Nifty 500
  • traded value 0.8× usual · delivery 55% vs 52% usual
  • FPI −1.0 pp · DII +0.5 pp · MF schemes in Sept 2026: 25 bought, 41 cut · no promoter pledge · insiders net bought ₹167 cr in 3 months · quarter ended 2026-09-30
  • Jun 2026 quarter: profit −57% year on year · revenue −45%
  • nothing scheduled or restricting

How big is it?

six-month average market cap

Market capitalisation
₹17,418 cr
Rank
#389
Cap band
Small Cap
Nearest cut-off — Mid / Small
−49.06% from ₹34,190 cr
Clear of the cut-off

Our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page.

Did buyers take delivery?

latest session · 2026-11-05

vs its own normal
2.0×
median 2,06,853
Delivered
4,08,625
Of volume
57%

Price & trend

Returns

to 05 Nov 2026

PeriodStockvs Nifty 500vs its industry
1 week+1.1%−4.4 pts—
1 month−3.3%−7.5 pts−6.9 pts
3 months−13.2%−11.3 pts−14.0 pts
6 months−30.7%−31.0 pts−37.5 pts
1 year−4.4%−1.9 pts—

Industry: Healthcare (Nifty 500 classification) · rank 40 of 44 over 3 months. Points = the stock’s return minus the benchmark’s. Prices adjusted for splits and bonuses.

Averages & movement

vs 20-day average
+0.9%
above
vs 50-day average
−2.2%
below
vs 200-day average
−14.1%
below
ATR (14)
2.2%
typical daily range
Volatility
15%
1 month, annualised
Beta
0.95
vs Nifty 500, 1 year
Traded value
0.8×
vs usual
Delivery
55%
usual 52%
From the 52-week high
−33.9%
place in range 4% (0 = at the low)

Ownership

Who owns the company

% of all shares, by quarter

GroupDec 25Mar 26Jun 26Sep 26
Promoters49.5%49.4% −0.149.4%49.4%
FPI15.2%17.4% +2.217.0% −0.416.0% −1.0
Mutual funds1.6%1.7% +0.11.9% +0.22.3% +0.3
Other DII3.8%3.7%3.7%3.9% +0.2
Individuals25.4%23.3% −2.123.4% +0.123.9% +0.4
Others4.6%4.4% −0.24.6% +0.14.6%

From the company’s quarterly shareholding pattern. Changes in percentage points against the quarter before. No quarters are on record between Sep 2022 and Jun 2025.

Promoter pledge

Sep 26

Of promoters’ holding
none
Of all shares
none
Jun 25 noneSep 25 noneDec 25 noneMar 26 noneJun 26 noneSep 26 none

Holders

Sep 26

All shareholders
4,04,135
Individuals
3,88,280

Indian passive funds’ stake

2026-06-30

Of free float
1.05%
Of all shares
0.53%
Schemes
62
Days to unwind
1.9
at 100% of volume

9,49,686 shares held by Indian passive mutual-fund schemes. A floor, not the total — foreign ETFs, insurance and EPFO are not counted.

Which funds bought and sold

mutual funds · quarter ended 2026-06-30

Funds holding
81
62 index · 19 active
Bought more
48
Sold some
12
FundSharesChangeDid
Edelweiss Nifty500 Multicap Momentum Quality 50 Index Fund-Reg(G)Index+22,257+222.1%bought
Bandhan Multi Cap Fund-Reg(G)Active+1,25,000+166.7%bought
Mirae Asset Nifty MidSmallcap400 Momentum Quality 100 ETFIndex+6,115+52.4%bought
JioBlackRock Flexi Cap Fund(G)-Direct PlanActive−1,65,584−79.4%sold
HDFC NIFTY Smallcap 250 ETFIndex−788−0.7%sold
Tata Nifty MidSmall Healthcare Index Fund-Reg(G)Index−125−0.5%sold

Ranked by how much each fund changed its own position, not by size of trade. Every fund here still holds the company — one that sold out entirely leaves no record to find.

Mutual-fund schemes, month by month

fund houses’ own monthly portfolios

MonthSchemesBought newAddedCutSold outShares heldValue
Sep 2672619365+20.4%₹300 cr
Aug 2671545103−2.4%₹253 cr
Jul 2669332196−2.3%₹283 cr
Jun 2672738131−3.3%₹294 cr
May 2666725180+9.3%₹332 cr
Apr 2659235110−1.5%₹327 cr

Each month against the one before, counting only the fund houses that reported both (45 houses in Sep 26); a split or bonus is divided out first. “Partial” = fewer than five houses reported yet.

Fund ownership is a quarterly disclosure and counts Indian passive schemes only.

Results

Results

Events & filings

Insider trades

SEBI PIT disclosures filed with NSE

Promoter group
Bought ₹166 cr (11)
Sold ₹0 (1)
Directors & KMP
Bought ₹0.92 cr (4)
Sold ₹0 (0)
Others
Bought ₹0.62 cr (10)
Sold ₹0 (0)
Latest 40 of 89 disclosures
0 selected
26 Oct 2026VENKAIAH CHOWDARY NANNAPANENIPromoter and DirectorBuy5,86,666₹44 cr0.15%Allotment
26 Oct 2026CHEKURI VENKAT RAMESHKMPBuy114₹85,5000.00%Allotment
26 Oct 2026NITIN JAIN (HUF)DirectorBuy3,000₹0.23 cr0.00%Allotment
26 Oct 2026SIVARAMAKRISHNA PRASAD POTLURIDirectorBuy4,000₹0.3 cr0.00%Allotment
26 Oct 2026LINGARAO DONTHINENIDirectorBuy5,157₹0.39 cr0.00%Allotment
26 Oct 2026KANTAMANI RATNA KUMARPromoter GroupBuy4,761₹0.36 cr0.00%Allotment
26 Oct 2026V S SWATHI KANTAMANIPromoter GroupBuy61,333₹4.6 cr0.08%Allotment
26 Oct 2026SAU FAMILY TRUSTPromoterBuy161₹0.01 cr0.00%Allotment
26 Oct 2026VISTRA ITCL LIMITED A/C VCN FAMILY TRUSTPromoterBuy161₹0.01 cr0.00%Allotment
26 Oct 2026VISTRA ITCL LIMITED A/C NEELIMA TRUSTPromoterBuy69,785₹5.23 cr0.02%Allotment
26 Oct 2026NATCO AQUA LIMITEDPromoter GroupBuy1,523₹0.11 cr0.00%Allotment
26 Oct 2026NATSOFT INFORMATION SYSTEMS PVT LTDPromoter GroupBuy2,40,000₹18 cr0.08%Allotment
26 Oct 2026TIME CAP PHAMA LABS PVT LTDPromoter GroupBuy9,33,333₹70 cr0.09%Allotment
26 Oct 2026RAJEEV NANNAPANENIPromoter and DirectorBuy58,666₹4.4 cr0.01%Allotment
26 Oct 2026NEELIMA SITA NANNAPANENIPromoterBuy2,55,387₹19.15 cr0.00%Allotment

Sums count buys and sells of equity (market and off-market); pledges are listed but not summed. From NSE’s filings: the archive to 2 May 2026, its XBRL filings since (NSE circular NSE/CML/2026/12). A filing describes what was done, not why.

Disclosures & deals

last six months · NSE filings

  • Scheme / acquisition
    Acquisition (including agreement to acquire)-XBRL NATCO PHARMA LIMITED has informed the Exchange regarding Acquisition (including agreement to acquire)
    28 Sept 2026
  • Board outcome
    Natco Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on September 09, 2026.
    09 Sept 2026
  • Scheme / acquisition
    Acquisition (including agreement to acquire)-XBRL NATCO PHARMA LIMITED has informed the Exchange regarding Acquisition (including agreement to acquire)
    25 Aug 2026
  • Board outcome
    Outcome of Board Meeting-XBRL NATCO PHARMA LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 14-Aug-2026 for Dividend
    14 Aug 2026
  • Board outcome
    Natco Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026 and declaration of Interim Dividend for the FY ending 2026-27
    14 Aug 2026
  • Scheme / acquisition
    Acquisition (including agreement to acquire)-XBRL NATCO PHARMA LIMITED has informed the Exchange regarding Acquisition (including agreement to acquire)
    08 Jul 2026

Latest shown; 8 in six months on all disclosures.

NATCOPHARM: only ratings, pledges, insider and takeover disclosures, buybacks, schemes, board outcomes and deals are listed. All deals.

Corporate actions

full published history

0 selected
RecentRights2:21—01 Oct 202601 Oct 2026at ₹750
RecentDividend₹1.5Interim20 Aug 202620 Aug 2026
EarlierDividend₹1.5Interim18 Feb 202618 Feb 2026
EarlierDividend₹1.5Interim20 Nov 202520 Nov 2025
EarlierDividend₹2Interim19 Aug 202519 Aug 2025
EarlierDividend₹1.5Interim18 Feb 202518 Feb 2025
EarlierDividend₹1.5Interim27 Nov 202427 Nov 2024
EarlierDividend₹3Interim23 Aug 202423 Aug 2024
EarlierDividend₹1.25Interim26 Feb 202426 Feb 2024
EarlierDividend₹1.25Interim24 Nov 202324 Nov 2023

16 shown. A falling price on an ex-date is not a loss: a dividend leaves the share as cash and a bonus multiplies the shares held.

Market capitalisation is our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page. Fund ownership is a quarterly disclosure and counts Indian passive schemes only. Nothing here is advice, a recommendation, or a view on the company.